ALGN vs. PFE
ALGN (Align Technology, Inc.) and PFE (Pfizer Inc.) are both stocks. Both are in the Healthcare sector — ALGN in Medical Devices, PFE in Drug Manufacturers - General. Over the past 10 years, ALGN returned 8.27%/yr vs 2.11%/yr for PFE. At a 0.26 correlation, their price movements are largely independent.
Performance
ALGN vs. PFE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ALGN achieves a 11.97% return, which is significantly higher than PFE's 8.79% return. Over the past 10 years, ALGN has outperformed PFE with an annualized return of 8.27%, while PFE has yielded a comparatively lower 2.11% annualized return.
ALGN
- 1D
- -0.95%
- 1M
- 8.09%
- YTD
- 11.97%
- 6M
- 5.69%
- 1Y
- -3.77%
- 3Y*
- -18.42%
- 5Y*
- -22.15%
- 10Y*
- 8.27%
PFE
- 1D
- 0.15%
- 1M
- 0.96%
- YTD
- 8.79%
- 6M
- 4.79%
- 1Y
- 12.89%
- 3Y*
- -7.78%
- 5Y*
- -3.35%
- 10Y*
- 2.11%
ALGN vs. PFE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ALGN Align Technology, Inc. | 11.97% | -25.11% | -23.90% | 29.92% | -67.91% | 22.98% | 91.51% | 33.24% | -5.74% | 131.13% |
PFE Pfizer Inc. | 8.79% | 0.65% | -2.22% | -41.26% | -10.41% | 66.70% | 3.07% | -6.91% | 24.82% | 15.90% |
Correlation
The correlation between ALGN and PFE is 0.39, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.39 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.18 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.24 |
Correlation (All Time) Calculated using the full available price history since Jan 30, 2001 | 0.26 |
The correlation between ALGN and PFE shifts across timeframes, from 0.18 (5 years) to 0.39 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
ALGN:
$12.52B
PFE:
$150.21B
ALGN:
$5.96
PFE:
$1.31
ALGN:
29.32
PFE:
19.98
ALGN:
3.08
PFE:
2.36
ALGN:
3.02
PFE:
1.67
ALGN:
$4.10B
PFE:
$63.32B
ALGN:
$2.77B
PFE:
$43.91B
ALGN:
$776.15M
PFE:
$16.94B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ALGN vs. PFE — Risk / Return Rank
ALGN
PFE
ALGN vs. PFE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Align Technology, Inc. (ALGN) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ALGN | PFE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.62 | ||
| Sortino ratioReturn per unit of downside risk | -0.70 | ||
| Omega ratioGain probability vs. loss probability | 1.05 | 1.12 | -0.07 |
| Calmar ratioReturn relative to maximum drawdown | -0.10 | 1.13 | -1.22 |
| Martin ratioReturn relative to average drawdown | -0.16 | 2.27 | -2.43 |
Loading charts...
Drawdowns
ALGN vs. PFE - Drawdown Comparison
The maximum ALGN drawdown since its inception was -92.83%, which is greater than PFE's maximum drawdown of -69.24%. Use the drawdown chart below to compare losses from any high point for ALGN and PFE.
Loading charts...
Drawdown Indicators
| ALGN | PFE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -92.83% | -69.24% | -23.59% |
Max Drawdown (1Y)Largest decline over 1 year | -39.73% | -11.47% | -28.26% |
Max Drawdown (3Y)Largest decline over 3 years | -67.59% | -40.43% | -27.16% |
Max Drawdown (5Y)Largest decline over 5 years | -82.89% | -58.96% | -23.93% |
Max Drawdown (10Y)Largest decline over 10 years | -82.89% | -58.96% | -23.93% |
Current DrawdownCurrent decline from peak | -76.05% | -45.68% | -30.37% |
Average DrawdownAverage peak-to-trough decline | -37.96% | -22.90% | -15.06% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 23.97% | 5.70% | +18.27% |
Volatility
ALGN vs. PFE - Volatility Comparison
Align Technology, Inc. (ALGN) has a higher volatility of 13.05% compared to Pfizer Inc. (PFE) at 5.07%. This indicates that ALGN's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ALGN | PFE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.05% | 5.07% | +7.98% |
Volatility (6M)Calculated over the trailing 6-month period | 29.02% | 14.62% | +14.40% |
Volatility (1Y)Calculated over the trailing 1-year period | 52.95% | 23.84% | +29.11% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 49.58% | 25.48% | +24.10% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.08% | 23.89% | +25.19% |
Dividends
ALGN vs. PFE - Dividend Comparison
ALGN has not paid dividends to shareholders, while PFE's dividend yield for the trailing twelve months is around 6.56%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ALGN Align Technology, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PFE Pfizer Inc. | 6.56% | 6.91% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.53% | 3.69% | 3.47% |
Financials
ALGN vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between Align Technology, Inc. and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ALGN vs. PFE - Profitability Comparison
ALGN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Align Technology, Inc. reported a gross profit of 736.59M and revenue of 1.04B. Therefore, the gross margin over that period was 70.8%.
PFE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a gross profit of 9.72B and revenue of 14.45B. Therefore, the gross margin over that period was 67.3%.
ALGN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Align Technology, Inc. reported an operating income of 141.96M and revenue of 1.04B, resulting in an operating margin of 13.7%.
PFE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported an operating income of 4.03B and revenue of 14.45B, resulting in an operating margin of 27.9%.
ALGN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Align Technology, Inc. reported a net income of 112.77M and revenue of 1.04B, resulting in a net margin of 10.8%.
PFE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a net income of 2.69B and revenue of 14.45B, resulting in a net margin of 18.6%.
Frequently Asked Questions
ALGN and PFE have a correlation of 0.39, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ALGN has higher volatility (13.05%) compared to PFE (5.07%). In terms of maximum drawdown, ALGN dropped -92.83% vs PFE's -69.24%.
PFE currently has the higher Sharpe Ratio (0.54 vs -0.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ALGN and PFE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer